These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10202883)

  • 1. Reference values for the midluteal plasma progesterone concentration: evidence from human menopausal gonadotropin-stimulated pregnancy cycles.
    Sallam HN; Sallam A; Ezzeldin F; Agamia AF; Abou-Ali A
    Fertil Steril; 1999 Apr; 71(4):711-4. PubMed ID: 10202883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal requirements for a successful outcome in anovulatory patients treated with human menopausal gonadotropins.
    Sallam HN; Sallam AN; Ezzeldin FE; Agamia AF; Abou-Ali AH
    Int J Fertil Womens Med; 2000; 45(4):285-91. PubMed ID: 10997485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteal phase support with hCG does not improve fecundity rate in human menopausal gonadotropin-stimulated cycles.
    Keenan JA; Moghissi KS
    Obstet Gynecol; 1992 Jun; 79(6):983-7. PubMed ID: 1579327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection of multiple gestations following hMG-hCG therapy by ultrasonography and midluteal phase progesterone determinations.
    Tanaka T; Sakuragi N; Fujimoto S; Ichinoe K; Mizoe J
    Int J Fertil; 1983; 28(3):184-7. PubMed ID: 6140241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimum values for midluteal plasma progesterone and estradiol concentrations in patients who achieved pregnancy with timed intercourse or intrauterine insemination without a human menopausal gonadotropin.
    Takaya Y; Matsubayashi H; Kitaya K; Nishiyama R; Yamaguchi K; Takeuchi T; Ishikawa T
    BMC Res Notes; 2018 Jan; 11(1):61. PubMed ID: 29357944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luteal phase hyperprolactinemia during ovulation induction with human menopausal gonadotropins: incidence, recurrence, and effect on pregnancy rates.
    Tippet PD; Simon JA; Rifka SM; Falk RJ
    Obstet Gynecol; 1989 Apr; 73(4):613-6. PubMed ID: 2494621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
    Gerris J; De Vits A; Joostens M; Van Royen E
    Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Peak follicular estradiol (E2) levels and midluteal progesterone/E2 ratios in ongoing pregnancies and nonconception cycles after ovulation induced with gonadotropins].
    Ellenbogen A; David H; Libal Y; Ballas S
    Harefuah; 1995 Dec; 129(11):455-6, 536. PubMed ID: 8846950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shortened luteal phase after ovulation induction with human menopausal gonadotropin and human chorionic gonadotropin.
    Olson JL; Rebar RW; Schreiber JR; Vaitukaitis JL
    Fertil Steril; 1983 Mar; 39(3):284-91. PubMed ID: 6402386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Native gonadotropin-releasing hormone for triggering follicular maturation in polycystic ovary syndrome patients undergoing human menopausal gonadotropin ovulation induction.
    Blumenfeld Z; Lang N; Amit A; Kahana L; Yoffe N
    Fertil Steril; 1994 Sep; 62(3):456-60. PubMed ID: 8062938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Luteal dysfunction in ovulation induction: the role of repetitive human chorionic gonadotropin supplementation during the luteal phase.
    Blumenfeld Z; Nahhas F
    Fertil Steril; 1988 Sep; 50(3):403-7. PubMed ID: 3137096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of progesterone/estradiol ratio on luteal function for achieving pregnancy in gonadotropin therapy.
    Kamada S; Kubota T; Aso T
    Horm Res; 1992; 37 Suppl 1():59-63. PubMed ID: 1427631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of luteal phase support protocol on cycle outcome and luteal phase hormone profile in long agonist protocol intracytoplasmic sperm injection cycles: a randomized clinical trial.
    Ghanem ME; Sadek EE; Elboghdady LA; Helal AS; Gamal A; Eldiasty A; Bakre NI; Houssen M
    Fertil Steril; 2009 Aug; 92(2):486-93. PubMed ID: 19464001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.
    Penzias AS; Shamma FN; Gutmann JN; Seifer DB; DeCherney AH; Lavy G
    J Assist Reprod Genet; 1992 Jun; 9(3):244-7. PubMed ID: 1525454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of ovulation with pulsatile subcutaneous administration of human menopausal gonadotropin in anovulatory infertile women.
    Nakamura Y; Yoshimura Y; Tanabe K; Iizuka R
    Fertil Steril; 1986 Jul; 46(1):46-54. PubMed ID: 3087790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of elevated serum progesterone during ovulation induction in in vitro fertilization-embryo transfer.
    Huang JC; Jackson KV; Hornstein MD; Ginsburg ES
    J Assist Reprod Genet; 1996 Sep; 13(8):617-24. PubMed ID: 8897120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The value of luteal support with progesterone in gonadotropin-induced cycles.
    Hamilton CJ; Jaroudi KA; Sieck UV
    Fertil Steril; 1993 Nov; 60(5):786-90. PubMed ID: 8224262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteal-phase ovarian stimulation is feasible for producing competent oocytes in women undergoing in vitro fertilization/intracytoplasmic sperm injection treatment, with optimal pregnancy outcomes in frozen-thawed embryo transfer cycles.
    Kuang Y; Hong Q; Chen Q; Lyu Q; Ai A; Fu Y; Shoham Z
    Fertil Steril; 2014 Jan; 101(1):105-11. PubMed ID: 24161646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone and ultrasound parameters in ovarian stimulation cycles for direct intraperitoneal insemination.
    Karlström PO; Bakos O; Bergh T; Lundkvist O
    Hum Reprod; 1992 Jul; 7(6):813-20. PubMed ID: 1500480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Midluteal Progesterone: A Marker of Treatment Outcomes in Couples With Unexplained Infertility.
    Hansen KR; Eisenberg E; Baker V; Hill MJ; Chen S; Talken S; Diamond MP; Legro RS; Coutifaris C; Alvero R; Robinson RD; Casson P; Christman GM; Santoro N; Zhang H; Wild RA;
    J Clin Endocrinol Metab; 2018 Jul; 103(7):2743-2751. PubMed ID: 29767754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.